Our overall goal is the establishment of a permanent Center for Translational Neuroscience (CTN) dedicated to, a) providing support for maintaining and expanding self-sufficient research cores developed during Phases I and II that are essential for the continuing conduct of basic, clinical, translational, and community based research, and b) sustaining a collaborative, multidisciplinary research environment by providing support for pilot study projects, as well as mentoring and training components. To attain this goal, we designed the following specific aims:
Aim 1 : To enhance the infrastructure critical to the CTN by supporting, upgrading, and streamlining three Core Facilities.
Aim 2 : To strengthen and augment translational mission relevant research through mentoring promising early career clinicians and basic scientists by established, dedicated senior Mentors.
Aim 3 : To expand our successful Career Development Program for CTN investigators and institute a new Leadership Program for established and young researchers, who will be required to meet specific Performance Milestones.
Aim 4 : To support a translational pilot study research program of cutting edge science, promote state wide and additional collaborations within the institution, and create opportunities to develop and maintain competitive research programs.
Aim 5 : To systematically collect, analyze, and use CTN information to answer questions about projects, cores, and policies, especially about their efficiency and effectiveness. An experienced Core Advisory Committee (CAC) will oversee operation and utilization of all the Core Facilities. The External Advisory Committee (EAC) will oversee scientific competitiveness of pilot studies and review progress of the Career Development Program and collaborative research. The Internal Advisory Committee (lAC) will oversee integration of early career investigators and issues related to recruitment, space, and promotion and tenure.
These aims will have a greater impact at a small institution such as ours and facilitate the solidification of a successful and productive CTN that will set an example for national programs. Our likely success is certified by generating over $30 million in new grant support and publishing over 450 articles and chapters in Phses I and II.

Public Health Relevance

We will create a truly unique translational research center with a realistic possibility of developing novel therapies for ameliorating the deficitis produced by brain disorders. Our efforts have already led to the development of several new therapies and treatments, and to a significant decrease in newborn mortality throughout the state.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Center Core Grants (P30)
Project #
3P30GM110702-03S1
Application #
9320362
Study Section
Special Emphasis Panel (ZGM1-TWD-C (3C))
Program Officer
Liu, Yanping
Project Start
2014-06-10
Project End
2019-04-30
Budget Start
2016-05-01
Budget End
2017-04-30
Support Year
3
Fiscal Year
2016
Total Cost
$374,488
Indirect Cost
$90,773
Name
University of Arkansas for Medical Sciences
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
122452563
City
Little Rock
State
AR
Country
United States
Zip Code
72205
González, Betina; Jayanthi, Subramaniam; Gomez, Natalia et al. (2018) Repeated methamphetamine and modafinil induce differential cognitive effects and specific histone acetylation and DNA methylation profiles in the mouse medial prefrontal cortex. Prog Neuropsychopharmacol Biol Psychiatry 82:1-11
Alexander, Tyler C; Butcher, Hannah; Krager, Kimberly et al. (2018) Behavioral Effects of Focal Irradiation in a Juvenile Murine Model. Radiat Res 189:605-617
Perissinotti, Paula P; Rivero-Echeto, María Celeste; Garcia-Rill, Edgar et al. (2018) Leptin alters somatosensory thalamic networks by decreasing gaba release from reticular thalamic nucleus and action potential frequency at ventrobasal neurons. Brain Struct Funct 223:2499-2514
Kiaei, Mahmoud; Balasubramaniam, Meenakshisundaram; Govind Kumar, Vivek et al. (2018) ALS-causing mutations in profilin-1 alter its conformational dynamics: A computational approach to explain propensity for aggregation. Sci Rep 8:13102
Kang, Young-Jin; Lewis, Hannah Elisabeth Smashey; Young, Mason William et al. (2018) Cell Type-specific Intrinsic Perithreshold Oscillations in Hippocampal GABAergic Interneurons. Neuroscience 376:80-93
Berquist, Michael D; Hyatt, William S; Bauer-Erickson, Jonathan et al. (2018) Phencyclidine-like in vivo effects of methoxetamine in mice and rats. Neuropharmacology 134:158-166
Gannon, Brenda M; Williamson, Adrian; Rice, Kenner C et al. (2018) Role of monoaminergic systems and ambient temperature in bath salts constituent 3,4-methylenedioxypyrovalerone (MDPV)-elicited hyperthermia and locomotor stimulation in mice. Neuropharmacology 134:13-21
Virmani, Tuhin; Pillai, Lakshmi; Glover, Aliyah et al. (2018) Impaired step-length setting prior to turning in Parkinson's disease patients with freezing of gait. Mov Disord 33:1823-1825
Garcia-Rill, Edgar; D'Onofrio, Stasia; Mahaffey, Susan C et al. (2018) Bottom-up gamma and bipolar disorder, clinical and neuroepigenetic implications. Bipolar Disord :
Nekouei, Mina; Ghezellou, Parviz; Aliahmadi, Atousa et al. (2018) Changes in biophysical characteristics of PFN1 due to mutation causing amyotrophic lateral sclerosis. Metab Brain Dis 33:1975-1984

Showing the most recent 10 out of 111 publications